Meet Dr. Tom Edwards! He is a Melbourne-based vitreoretinal surgeon who also leads a research team investigating retinal gene therapy at the University of Melbourne affiliated Centre for Eye Research Australia (CERA) based at the Royal Victoria Eye and Ear Hospital.
Dr. Edwards is working on a number of research projects, including an ongoing world first clinical trial of gene therapy to treat choroideremia, a type of inherited retinal degeneration that leads to blindness. He will be presenting about Gene Therapy during the 17th Annual Meeting!
The 17th annual meeting of the WAEH is approaching! From October the 10th till October the 14th we will visit the The Royal Victorian Eye and Ear Hospital from Melbourne and the Sydney Eye Hospital and the Chatswood Private Hospital from Sydney. We will be talking about Quality and Safety in Eye Care, Innovation, Philanthropy, Sustainability, and Workforce!
Curious about Gene Therapy and interested in joining the Annual Meeting? Register now!
Want to know more about education for nurses and allied health personnel?
Please join the WAEH Community of Practice: Research impact on clinical practice on 27 February 2024. With presenter Tendai Gwenhure, Clinical Educator (Lead for Student Nurse’s/ RTP Nurses), and Roxanne […]
New ISBCS Implementation Manual Released, Accompanied by BICAT-NL Implementation Project Website Launch
The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) involving 865 […]
Same-day bilateral cataract surgery – breaking down the barriers
WAEH Webinar The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) […]
Study calls for thorough investigation of patients with early signs of retinal vascular disease
News from our member Moorfields Eye Hospital NHS Foundation Trust, United Kingdom Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk […]